Building a resilient drug supply chain

An emergency situation can surface vulnerabilities in the supply chain that threaten the ability to provide drugs to those who need them.

On the demand side, an increased need for certain drugs can stretch manufacturing capabilities. On the supply side, drugs simply cannot be manufactured or transported if there are system-wide shutdowns, workforce challenges, or a transportation network is interrupted.

In this report, we describe existing strategies to avoid shortages and review how Cortellis Generics Intelligence™ and Cortellis Supply Chain Network™ provide the insights needed to find the best partners and plan for the unexpected.